These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects. Lin TY, Yang MH, Chang FY. Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449 [Abstract] [Full Text] [Related]
6. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies. Williams DD, Peng B, Bailey CK, Wire MB, Deng Y, Park JW, Collins DA, Kapsi SG, Jenkins JM. Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149 [Abstract] [Full Text] [Related]
7. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation. Sauron R, Wilkins M, Jessent V, Dubois A, Maillot C, Weil A. Int J Clin Pharmacol Ther; 2006 Feb; 44(2):64-70. PubMed ID: 16502765 [Abstract] [Full Text] [Related]
8. Bioavailability of modified-release methylphenidate: influence of high-fat breakfast when administered intact and when capsule content sprinkled on applesauce. Lee L, Kepple J, Wang Y, Freestone S, Bakhtiar R, Wang Y, Hossain M. Biopharm Drug Dispos; 2003 Sep; 24(6):233-43. PubMed ID: 12973820 [Abstract] [Full Text] [Related]
10. The Lidose hard capsule formulation of fenofibrate is suprabioavailable compared to the nanoparticle tablet formulation under high-fat fed conditions. Verbeeck RK, De Niet S, Lebrun S, Tremege M, Rennie TW, Coffiner M, Streel B, Cahay B. J Pharm Pharm Sci; 2015 Sep; 18(1):61-7. PubMed ID: 25877442 [Abstract] [Full Text] [Related]
11. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects. Disanto AR, Golden G. Clin Drug Investig; 2009 Sep; 29(8):539-49. PubMed ID: 19591515 [Abstract] [Full Text] [Related]
12. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast. Schug BS, Brendel E, Wonnemann M, Wolf D, Wargenau M, Dingler A, Blume HH. Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144 [Abstract] [Full Text] [Related]
14. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast. Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH. Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482 [Abstract] [Full Text] [Related]
15. An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers. Martin PD, Dane AL, Schneck DW, Warwick MJ. Clin Ther; 2003 Feb; 25(2):459-71. PubMed ID: 12749507 [Abstract] [Full Text] [Related]
16. Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition . Park JM, Chae SI, Noh YS, Lee SJ, Shim WS, Yoon JM, Hwang SJ, Lee KT, Chung EK. Int J Clin Pharmacol Ther; 2019 Apr; 57(4):217-228. PubMed ID: 30802201 [Abstract] [Full Text] [Related]
17. Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women. Teo SK, Scheffler MR, Kook KA, Tracewell WG, Colburn WA, Stirling DI, Thomas SD. Biopharm Drug Dispos; 2000 Jan; 21(1):33-40. PubMed ID: 11038436 [Abstract] [Full Text] [Related]